Literature DB >> 10666456

Regulation of double-strand break-induced mammalian homologous recombination by UBL1, a RAD51-interacting protein.

W Li1, B Hesabi, A Babbo, C Pacione, J Liu, D J Chen, J A Nickoloff, Z Shen.   

Abstract

Mammalian RAD51 protein plays essential roles in DNA homologous recombination, DNA repair and cell proliferation. RAD51 activities are regulated by its associated proteins. It was previously reported that a ubiquitin-like protein, UBL1, associates with RAD51 in the yeast two-hybrid system. One function of UBL1 is to covalently conjugate with target proteins and thus modify their function. In the present study we found that non-conjugated UBL1 forms a complex with RAD51 and RAD52 proteins in human cells. Overexpression of UBL1 down-regulates DNA double-strand break-induced homologous recombination in CHO cells and reduces cellular resistance to ionizing radiation in HT1080 cells. With or without overexpressed UBL1, most homologous recombination products arise by gene conversion. However, overexpression of UBL1 reduces the fraction of bidirectional gene conversion tracts. Overexpression of a mutant UBL1 that is incapable of being conjugated retains the ability to inhibit homologous recombination. These results suggest a regulatory role for UBL1 in homologous recombination.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666456      PMCID: PMC102610          DOI: 10.1093/nar/28.5.1145

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  91 in total

1.  Interaction of human recombination proteins Rad51 and Rad54.

Authors:  E I Golub; O V Kovalenko; R C Gupta; D C Ward; C M Radding
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

2.  Chromosomal double-strand breaks induce gene conversion at high frequency in mammalian cells.

Authors:  D G Taghian; J A Nickoloff
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p.

Authors:  E S Johnson; G Blobel
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

4.  Ubch9 conjugates SUMO but not ubiquitin.

Authors:  J M Desterro; J Thomson; R T Hay
Journal:  FEBS Lett       Date:  1997-11-17       Impact factor: 4.124

5.  Elevated recombination in immortal human cells is mediated by HsRAD51 recombinase.

Authors:  S J Xia; M A Shammas; R J Shmookler Reis
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

Review 6.  SUMO-1: wrestling with a new ubiquitin-related modifier.

Authors:  H Saitoh; R T Pu; M Dasso
Journal:  Trends Biochem Sci       Date:  1997-10       Impact factor: 13.807

7.  Interaction of p53 with the human Rad51 protein.

Authors:  S Buchhop; M K Gibson; X W Wang; P Wagner; H W Stürzbecher; C C Harris
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

8.  Function of yeast Rad52 protein as a mediator between replication protein A and the Rad51 recombinase.

Authors:  P Sung
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

9.  BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.

Authors:  A Petrij-Bosch; T Peelen; M van Vliet; R van Eijk; R Olmer; M Drüsedau; F B Hogervorst; S Hageman; P J Arts; M J Ligtenberg; H Meijers-Heijboer; J G Klijn; H F Vasen; C J Cornelisse; L J van 't Veer; E Bakker; G J van Ommen; P Devilee
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

10.  Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9.

Authors:  L Gong; T Kamitani; K Fujise; L S Caskey; E T Yeh
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

View more
  21 in total

Review 1.  Manipulating the mammalian genome by homologous recombination.

Authors:  K M Vasquez; K Marburger; Z Intody; J H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

2.  SUMO modified proteins localize to the XY body of pachytene spermatocytes.

Authors:  Richard S Rogers; Amy Inselman; Mary Ann Handel; Michael J Matunis
Journal:  Chromosoma       Date:  2004-09-03       Impact factor: 4.316

3.  Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis.

Authors:  Stergios J Moschos; Yin-Yuan Mo
Journal:  J Mol Histol       Date:  2006-06-07       Impact factor: 2.611

Review 4.  SUMO junction-what's your function? New insights through SUMO-interacting motifs.

Authors:  Oliver Kerscher
Journal:  EMBO Rep       Date:  2007-06       Impact factor: 8.807

5.  The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair.

Authors:  Huimei Lu; Xu Guo; Xiangbing Meng; Jingmei Liu; Chris Allen; Justin Wray; Jac A Nickoloff; Zhiyuan Shen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 6.  SUMO and SUMOylation in plants.

Authors:  Hee Jin Park; Woe-Yeon Kim; Hyeong Cheol Park; Sang Yeol Lee; Hans J Bohnert; Dae-Jin Yun
Journal:  Mol Cells       Date:  2011-09-09       Impact factor: 5.034

7.  DNA-dependent protein kinase suppresses double-strand break-induced and spontaneous homologous recombination.

Authors:  Chris Allen; Akihiro Kurimasa; Mark A Brenneman; David J Chen; Jac A Nickoloff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

8.  Role of Cdc48/p97 as a SUMO-targeted segregase curbing Rad51-Rad52 interaction.

Authors:  Steven Bergink; Tim Ammon; Maximilian Kern; Lothar Schermelleh; Heinrich Leonhardt; Stefan Jentsch
Journal:  Nat Cell Biol       Date:  2013-04-28       Impact factor: 28.824

9.  Small ubiquitin-like modifier (SUMO) isoforms and conjugation-independent function in DNA double-strand break repair pathways.

Authors:  Yiheng Hu; Jeffrey D Parvin
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

10.  SUMO modification of Rad22, the Schizosaccharomyces pombe homologue of the recombination protein Rad52.

Authors:  J C Ho; N J Warr; H Shimizu; F Z Watts
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.